Immunodominant domains present on the Bordetella pertussis vaccine component filamentous hemagglutinin

Journal of Infectious Diseases

Volumn 175, Issue 6, 1997, Pages 1423-1431

  Leininger, Elizabeth ^b   Bowen, Steven ^c   Renauld Mongénie, Genevieve ^c   Rouse, Julie H ^c   Menozzi, Franco D ^c   Locht, Camille ^c   Heron, Iver ^c   Brennan, Michael J ^a  

^a Division of Cellular and Gene Therapies   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c Pasteur Merieux SV ^*

Author keywords

[No Author keywords available]

Indexed keywords

PERTUSSIS VACCINE;

AMINO ACID SEQUENCE; ARTICLE; BORDETELLA PARAPERTUSSIS; DRUG FORMULATION; EPITOPE MAPPING; HUMAN; IMMUNOBLOTTING; IMMUNOGENICITY; NONHUMAN; PERTUSSIS; PRIORITY JOURNAL; VACCINE PRODUCTION;

EID: 0030946156     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/516475     Document Type: Article

References (15)

1. Locht C, Bertin P, Menozzi FD, Renauld G. The filamentous hemagglutinin, a multifaceted adhesin produced by virulent Bordetella spp. Mol Microbiol 1993;9:653-60.
2. Sato Y, Cowell JL, Sato H, Burstyn DG, Manclark CR. Separation and purification of the hemagglutinins from Bordetella pertussis. Infect Immun 1983;41:313-20.
3. Urisu A, Cowell JL, Manclark CR. Filamentous hemagglutinin has a major role in mediating adherence of Bordetella pertussis to human WiDr cells. Infect Immun 1986;52:695-701.
4. Menozzi FD, Boucher PE, Riveau G, Gantiez C, Locht C. Surface-associated filamentous hemagglutinin induces autoagglutination of Bordetella pertussis. Infect Immun 1994;62:4261-9.
5. Tuomanen E. Piracy of adhesins: attachment of superinfecting pathogens to respiratory cilia by secreted adhesins of Bordetella pertussis. Infect Immun 1986;54:905-8.
6. Leininger E, Ewanowich CA, Bhargava A, Peppier MS, Kenimer JG, Brennan MJ. Comparative roles of the Arg-Gly-Asp sequence present in the Bordetella pertussis adhesins pertactin and filamentous hemagglutinin. Infect Immun 1992; 60:2380-5.
7. Relman DA, Domenighini M, Tuomanen E, Rappuoli R, Falkow S. Filamentous hemagglutinin of Bordetella pertussis: nucleotide sequence and crucial role in adherence. Proc Natl Acad Sci USA 1989; 86: 2637-41.
8. Menozzi FD, Gantiez C, Locht C. Interaction of the Bordetella pertussis filamentous hemagglutinin with heparin. FEMS Microbiol Lett 1991; 78:59-64.
9. Hannah JH, Menozzi FD, Renauld G, Locht C, Brennan MJ. Sulfated glyconjugate receptors for the Bordetella pertussis adhesin filamentous hemagglutinin (FHA) and mapping of the heparin-binding domain on FHA. Infect Immun 1994;62:5010-9.
10. Prasad SM, Yin Y, Rodzinski E, Tuomanen El, Masure HR. Identification of a carbohydrate recognition domain in filamentous hemagglutinin from Bordetella pertussis. Infect Immun 1993;61:2780-5.
11. Kimura A, Mountzouros KT, Relman DA, Falkow S, Cowell JL. Bordetella pertussis filamentous hemagglutinin: evaluation as a protective antigen and colonization factor in a mouse respiratory infection model. Infect Immun 1990; 58:7-16.
12. Shahin RD, Amsbaugh DF, Leef MF. Mucosal immunization with filamentous hemagglutinin protects against Bordetella pertussis respiratory infection. Infect Immun 1992;60:1482-8.
13. Amsbaugh DF, Li ZM, Shahin RD. Long-lived respiratory immune response to filamentous hemagglutinin following Bordetella pertussis infection. Infect Immun 1993;61:1447-52.
14. Cherry JD. Acellular pertussis vaccines - a solution to the pertussis problem. J Infect Dis 1993; 168:21-4.
15. Greco D, Salmaso S, Mastrantonio P, et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N Engl J Med 1996;334:341-8.